REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $305,880 | +12.1% | 3,000 | 0.0% | 0.03% | +3.6% |
| Q1 2023 | $272,760 | -43.8% | 3,000 | -40.0% | 0.03% | -34.9% |
| Q3 2021 | $485,000 | -14.0% | 5,000 | -11.5% | 0.04% | -36.8% |
| Q1 2021 | $564,000 | -15.6% | 5,650 | +4.6% | 0.07% | -22.7% |
| Q4 2020 | $668,000 | – | 5,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |